NCT00035126View on ClinicalTrials.gov

EPO906 Therapy in Patients With Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Breast Neoplasms
Interventions
DRUG

epothilone b

Trial Locations (2)

03756

Dartmouth Hitchcock Medical Center, Lebanon

08901

Cancer Institute of New Jersey (CINJ), New Brunswick

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY